Literature DB >> 9851523

Cancer immunotherapy by direct in vivo transfer of immunomodulatory genes.

P Leroy1, P Slos, H Homann, P Erbs, Y Poitevin, E Regulier, F Q Colonna, P Devauchelle, C Roth, A Pavirani, M Mehtali.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9851523     DOI： 10.1016/s0923-2494(99)80038-8

Source DB:  PubMed          Journal:  Res Immunol        ISSN： 0923-2494


× No keyword cloud information.
  3 in total

Review 1.  Immunomodulation of cancer: potential use of selectively replicating agents.

Authors:  S Agha-Mohammadi; M T Lotze
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

2.  A novel immunocompetent murine tumor model for the evaluation of RCAd-enhanced RDAd transduction efficacy.

Authors:  Huiping Wang; Fang Wei; Jufeng Zhang; Feng Wang; Huiming Li; Xiafang Chen; Kuangcheng Xie; Yufei Wang; Chuanyuan Li; Qian Huang
Journal:  Tumour Biol       Date:  2012-05-25

3.  Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings.

Authors:  E Tartour; M Mehtali; X Sastre-Garau; I Joyeux; C Mathiot; J M Pleau; P Squiban; C Rochlitz; M Courtney; P Jantscheff; R Herrmann; P Pouillart; W H Fridman; T Dorval
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.